ArticleExperimental and therapeutic medicine2022

Comparison of a histone deacetylase inhibitor plus exemestane with exemestane alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: A meta-analysis.

Liang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.